Patent directory · USPTO A61K / A61P
Patents matching “Takeda Pharmaceutical Company Limited”
1,022 pharma patents match "Takeda Pharmaceutical Company Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,022 pharmaceutical patents matching "Takeda Pharmaceutical Company Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12091675
Gene therapy of hemophilia a using viral vectors encoding recombinant FVIII variants with increased expression
granted -
US 12084436
Heterocyclic compound
granted -
US 12084515
Compositions and methods for treatment of diabetic macular edema
granted -
US 12084431
Pharmaceutical salts of pyrimidine derivatives and method of treating disorders
granted -
US 12077522
Heterocyclic compound and application thereof
granted -
US 12071434
Heterocyclic compound
granted -
US 12071468
Purification of Factor VIII subspecies
granted -
US 12065448
Heteroaryl plasma kallikrein inhibitors
granted -
US 12061206
Diagnosis and treatment of autoimmune diseases
granted -
US 12060382
Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1 β-L-ribofuranosyl)-1H-benzimidazole
granted -
US 12054474
Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases
granted -
US 12053526
Methods for treatment using anti-alpha4beta7 antibody
granted -
US 12048699
Cancer treatment methods based on TP53 mutation status and hypermutation
granted -
US 12031130
Composition for modifying target gene
granted -
US 12024505
Heterocyclic compounds useful as modulators of acetylcholine receptors
granted -
US 12024512
Cocrystal
granted -
US 12016904
Treatment of gastrointestinal bleeding in patients with severe von Willebrand disease by administration of recombinant VWF
granted -
US 12018281
Cardiomyocyte maturation promoter
granted -
US 12012419
Heterocyclic compound
granted -
US 12005054
Piperidinyl-3-(aryloxy)propanamides and propanoates
granted -
US 11993570
Cationic lipids
granted -
US 11987586
Pyrrolo[1,2-c]imidazole derivatives as orexin type 2 receptor agonists
granted -
US 11981912
Adeno associated virus vectors for the treatment of hunter disease
granted -
US 11970483
Heterocyclic compound
granted